183 related articles for article (PubMed ID: 16522890)
1. Cancer-treatment-induced bone loss, part 2.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
[TBL] [Abstract][Full Text] [Related]
2. Cancer-treatment-induced bone loss, part 1.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
[TBL] [Abstract][Full Text] [Related]
3. Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.
Diana A; Carlino F; Giunta EF; Franzese E; Guerrera LP; Di Lauro V; Ciardiello F; Daniele B; Orditura M
Curr Treat Options Oncol; 2021 Apr; 22(5):45. PubMed ID: 33864145
[TBL] [Abstract][Full Text] [Related]
4. Management of bone loss due to endocrine therapy during cancer treatment.
Khan MI
Osteoporos Int; 2023 Apr; 34(4):671-680. PubMed ID: 36656338
[TBL] [Abstract][Full Text] [Related]
5. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
Body JJ; Bergmann P; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Reginster JY; Rozenberg S; Kaufman JM
Osteoporos Int; 2007 Nov; 18(11):1439-50. PubMed ID: 17690930
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment-induced bone loss in patients with breast or prostate cancer.
Maxwell C; Viale PH
Oncol Nurs Forum; 2005 May; 32(3):589-603. PubMed ID: 15897934
[TBL] [Abstract][Full Text] [Related]
8. Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.
Michaud LB
Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 3):S20-30; quiz S31-3. PubMed ID: 20332495
[TBL] [Abstract][Full Text] [Related]
9. Early breast and prostate cancer and clinical outcomes (fracture).
Chlebowski RT; Tagawa T
Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):16-20. PubMed ID: 20128324
[TBL] [Abstract][Full Text] [Related]
10. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
11. [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].
Takahashi S
Clin Calcium; 2011 Aug; 21(8):1239-47. PubMed ID: 21814031
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy with bone-targeted agents.
Wilson C; Coleman RE
Curr Opin Support Palliat Care; 2011 Sep; 5(3):241-50. PubMed ID: 21785355
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the management of cancer treatment induced bone loss.
Bertoldo F; Pancheri S; Zenari S; Boldini S
Expert Opin Emerg Drugs; 2010 Jun; 15(2):323-42. PubMed ID: 20377485
[TBL] [Abstract][Full Text] [Related]
15. The role of bisphosphonates in the adjuvant setting for breast cancer.
Reeder JG; Brufsky AM
Oncology (Williston Park); 2010 May; 24(6):462-7, 475. PubMed ID: 20568587
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of side-effects of systemic treatment: bone loss.
Body JJ
Ann Oncol; 2010 Oct; 21 Suppl 7():vii180-5. PubMed ID: 20943612
[TBL] [Abstract][Full Text] [Related]
17. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.
Brufsky AM
Expert Opin Pharmacother; 2008 Apr; 9(6):1013-28. PubMed ID: 18377343
[TBL] [Abstract][Full Text] [Related]
19. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
